|
1
|
Goldberg RJ, Spencer FA, Gore JM, Lessard
D and Yarzebski J: Thirty-year trends (1975 to 2005) in the
magnitude of, management of, and hospital death rates associated
with cardiogenic shock in patients with acut: A population-based
perspective. Circulation. 119:1211–1219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McManus DD, Chinali M, Saczynski JS, Gore
JM, Yarzebski J, Spencer FA, Lessard D and Goldberg RJ: 30-year
trends in heart failure in patients hospitalized with acute
myocardial infarction. Am J Cardiol. 107:353–359. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shyu KG, Wang BW, Cheng WP and Lo HM:
MicroRNA-208a increases myocardial endoglin expression and
myocardial fibrosis in acute myocardial infarction. Can J Cardiol.
31:679–690. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Y, Cheng HW, Qiu Y, Dupee D, Noonan
M, Lin YD, Fisch S, Unno K, Sereti KI and Liao R: MicroRNA-34a
plays a key role in cardiac repair and regeneration following
myocardial infarction. Circ Res. 117:450–459. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang J, Huang W, Cai W, Wang L, Guo L,
Paul C, Yu XY and Wang Y: Inhibition of microRNA-495 enhances
therapeutic angiogenesis of human induced pluripotent stem cells.
Stem Cells. 35:337–350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dang K and Myers KA: The role of
hypoxia-induced miR-210 in cancer progression. Int J Mol Sci.
16:6353–6372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeng LL, He XS, Liu JR, Zheng CB, Wang YT
and Yang GY: Lentivirus-mediated overexpression of MicroRNA-210
improves long-term outcomes after focal cerebral ischemia in mice.
CNS Neurosci Ther. 22:961–969. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Y, Zhang J, Xia T, Li G, Tian T, Wang
M, Wang R, Zhao L, Yang Y, Lan K and Zhou W: MicroRNA-210 promotes
cancer angiogenesis by targeting fibroblast growth factor
receptor-like 1 in hepatocellular carcinoma. Oncol Rep.
36:2553–2562. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Pan X, Fan Y, Hu X, Liu X, Xiang M
and Wang J: Dysregulated expression of microRNAs and mRNAs in
myocardial infarction. Am J Transl Res. 7:2291–2304.
2015.PubMed/NCBI
|
|
11
|
Wang J, Zhang Y, Liu YM, Guo LL, Wu P,
Dong Y and Wu GJ: Huoxue Anxin Recipe (HAR) promotes myocardium
angiogenesis of acute myocardial infarction rats by up-regulating
miR-210 and vascular endothelial growth factor. Chin J Integr Med.
22:685–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mineo TC, Ambrogi V, Baldi A, Rabitti C,
Bollero P, Vincenzi B and Tonini G: Prognostic impact of VEGF,
CD31, CD34, and CD105 expression and tumour vessel invasion after
radical surgery for IB-IIA non-small cell lung cancer. J Clin
Pathol. 57:591–597. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ye P, Liu J, He F, Xu W and Yao K:
Hypoxia-induced deregulation of miR-126 and its regulative effect
on VEGF and MMP-9 expression. Int J Med Sci. 11:17–23. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Levine GN, Bates ER, Blankenship JC,
Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA,
Hollenberg SM, et al: 2015 ACC/AHA/SCAI focused update on primary
percutaneous coronary intervention for patients with ST-elevation
myocardial infarction: An update of the 2011 ACCF/AHA/SCAI
guideline for percutaneous coronary intervention and the 2013
ACCF/AHA guideline for the management of ST-elevatio myocardial
infarction. J Am Coll Cardiol. 67:1235–1250. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Q, Yu P, Zeng Q, Luo B, Cai S, Hui K,
Yu G, Zhu C, Chen X, Duan M and Sun X: Neuroprotective effect of
hydrogen-rich saline in global cerebral ischemia/reperfusion rats:
Up-regulated tregs and down-regulated miR-21, miR-210 and NF-κB
expression. Neurochem Res. 41:2655–2665. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gorin C, Rochefort GY, Bascetin R, Ying H,
Lesieur J, Sadoine J, Beckouche N, Berndt S, Novais A, Lesage M, et
al: Priming dental pulp stem cells with fibroblast growth factor-2
increases angiogenesis of implanted tissue-engineered constructs
through hepatocyte growth factor and vascular endothelial growth
factor secretion. Stem Cells Transl Med. 5:392–404. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaga T, Kawano H, Sakaguchi M, Nakazawa T,
Taniyama Y and Morishita R: Hepatocyte growth factor stimulated
angiogenesis without inflammation: Differential actions between
hepatocyte growth factor, vascular endothelial growth factor and
basic fibroblast growth factor. Vascul Pharmacol. 57:3–9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Awada HK, Johnson NR and Wang Y: Dual
delivery of vascular endothelial growth factor and hepatocyte
growth factor coacervate displays strong angiogenic effects.
Macromol Biosci. 14:679–686. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sulpice E, Ding S, Muscatelli-Groux B,
Bergé M, Han ZC, Plouet J, Tobelem G and Merkulova-Rainon T:
Cross-talk between the VEGF-A and HGF signalling pathways in
endothelial cells. Biol Cell. 101:525–539. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saadoun S, Papadopoulos MC, Hara-Chikuma M
and Verkman AS: Impairment of angiogenesis and cell migration by
targeted aquaporin-1 gene disruption. Nature. 434:786–792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sanada F, Taniyama Y, Iekushi K, Azuma J,
Okayama K, Kusunoki H, Koibuchi N, Doi T, Aizawa Y and Morishita R:
Negative action of hepatocyte growth factor/c-Met system on
angiotensin II signaling via ligand-dependent epithelial growth
factor receptor degradation mechanism in vascular smooth muscle
cells. Circ Res. 105:667–675. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sanada F, Taniyama Y, Azuma J, Iekushi K,
Dosaka N, Yokoi T, Koibuchi N, Kusunoki H, Aizawa Y and Morishita
R: Hepatocyte growth factor, but not vascular endothelial growth
factor, attenuates angiotensin II-induced endothelial progenitor
cell senescence. Hypertension. 53:77–82. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang BW, Wu GJ, Cheng WP and Shyu KG:
Mechanical stretch via transforming growth factor-β1 activates
microRNA-208a to regulate hypertrophy in cultured rat cardiac
myocytes. J Formos Med Assoc. 112:635–643. 2013. View Article : Google Scholar : PubMed/NCBI
|
